Menu
Search
|

Menu

Close
X

Hutchison China MediTech Ltd HCM.OQ (NASDAQ Stock Exchange Global Select Market)

33.72 USD
-0.09 (-0.27%)
As of Feb 17
chart
Previous Close 33.81
Open 33.51
Volume 10,745
3m Avg Volume 29,646
Today’s High 33.96
Today’s Low 32.38
52 Week High 42.00
52 Week Low 12.67
Shares Outstanding (mil) --
Market Capitalization (mil) --
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.00 Mean rating from 4 analysts

KEY STATS

Revenue
No Data Available
FY
-
FY
-
FY
-
FY
-
EPS
No Data Available
FY
-
FY
-
FY
-
FY
-

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
--
5.77
Price to Book (MRQ)
vs sector
--
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
--
16.52
LT Debt to Equity (MRQ)
vs sector
--
12.22
Return on Investment (TTM)
vs sector
--
14.43
Return on Equity (TTM)
vs sector
--
16.13

EXECUTIVE LEADERSHIP

Simon To
Executive Chairman of the Board, Since 2006
Salary: $19,503.00
Bonus: --
Christian Hogg
Chief Executive Officer, Executive Director, Since 2006
Salary: $348,888.00
Bonus: $615,385.00
Chig Fung Cheng
Chief Financial Officer, Executive Director, Since 2011
Salary: $273,551.00
Bonus: $217,949.00
Weiguo Su
Executive Director, Since 2017
Salary: --
Bonus: --
Edith Shih
Company Secretary, Non-Executive Director, Since 2006
Salary: $19,503.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

22Nd Floor Hutchison House
10 Harcourt Road
    00000

Phone:

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures markets and distributes prescription drugs and consumer health products in China.

SPONSORED STORIES